Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GKAP1 | CTRPv2 | pan-cancer | AAC | -0.28 | 1e-14 |
mRNA | TLX2 | CTRPv2 | pan-cancer | AAC | -0.27 | 5e-05 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-12 |
mRNA | DCK | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-10 |
mRNA | C14orf132 | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-09 |
mRNA | WDR76 | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-11 |
mRNA | SAP30 | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-10 |
mRNA | THAP9 | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-11 |
mRNA | PRPS1 | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-11 |
mRNA | SENP1 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-11 |